In general, activation of PPARγ by agonists exerts inhibitory effects on tumor growth by various mechanisms, including apoptosis, cell cycle arrest and inhibitions of angiogenesis or differentiation [12,13,14,15]. Here, PPARG is linked to neoplasm.